chrisvoncsefalvay/vaers-outcomes huggingface dataset:
tested positive for COVID 19; tested positive for COVID 19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: LOSARTAN; VERAPAMIL; DOXAZOSIN; JANUVIA; METFORMIN; GLIMEPIRIDE; LEVOTHYROXINE.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "tested positive for COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: he's tested positive for COVID 19. Clinical information: Consumer states that he was been fully vaccinated with Pfizer COVID 19 vaccine, the primary series and 2 booster doses, and he was tested positive for COVID 19. He also takes Losartan, Verapamil, Doxazosin, Januvia, Metformin, Glimepiride, and Levothyroxine. Patient took his first dose of Paxlovid about 1/2 hour ago and asking can he take next dose in 12 hours and how he should take. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
This spontaneous report as received from a 77 year old male patient refers to himself. The patient had no drug reactions or allergies. On unknown date in 2011 (reported as 3 years ago) the patient was vaccinated with ZOSTAVAX (dose, route, lot # not reported). Concomitant therapies included unspecified analgesic, LYRICA, LORTAB and NEURONTIN. On approximately 20-AUG-2014 (reported as "11 weeks ago") the patient experienced a rash on top and back of head and also left ear. Moreover had unrelenting throbbing and extreme burning. Treatment was given for the events and unspecified lab diagnostic studies were performed. The outcome of extreme burning, unrelenting throbbing and a rash on top and back of head and also left ear was not reported. Relatedness between the events and ZOSTAVAX was not specified. Additional information is not expected as there was no contact details provided.
Swollen and sore to touch under left arm which is the arm I received the injection in.
Symptom onset was 9/23 with nausea and diarrhea, with positive Covid test on 9/24.  Patient vaccinated with J&J last April.  On presentation of ED, pt required 1 L oxygen to maintain saturations.  No baseline O2 requirements. Right lower quadrant abdominal tenderness was evaluated with abdominal CT which was negative for acute abdominal process.  CXR showed bilateral ground glass opacities consistent with COVID-19, CT PE negative for PE. Pt started on remdesivir and dexamethasone for treatment of COVID  Recovered and was discharged on 10/1/21
p/vax pt presented w/more than sixty skin lesions;it was reported that this pt was one of triplets;
After taking the second Moderna vaccine for Covid-19, I felt weakness and pain in my right leg, followed by weakness and pain in my left leg, followed by pain in my left arm. This was accompanied with a lot of fatigue. This was subsequently diagnosed as a re-occurrence of Guillain Barre Syndrome. I had Guillain Barre the first time at age 7, but I recovered from it completely until it re-occurred after taking the Moderna vaccines.
After the second dose he had muscle aches, achiness, and a scratchy throat; After the second dose he had muscle aches, achiness, and a scratchy throat; After the second dose he had muscle aches, achiness, and a scratchy throat; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162B2 (Dose 1, Batch/Lot number: unknown), for covid-19 immunization, reactions: "fatigued" and "wiped out". The following information was reported: MYALGIA (non-serious), PAIN (non-serious), THROAT IRRITATION (non-serious), outcome "unknown" and all described as "After the second dose he had muscle aches, achiness, and a scratchy throat".  Additional information: Caller reported that her husband was fully vaccinated and he had some mild side effects but he seemed to have sailed through it. She does not know if it was from the vaccine but after the first dose he was wiped out and fatigued and had to lie down. After the second dose he had muscle aches, achiness, and a scratchy throat  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021360082 same reporter/patient/drug, different dose/events.
mom phoned 830AM 13OCT98 said pt had broken out w/chickenpox also another sibling had broke out p/another sibling that did not have vaccine broke out w/chickenpox;rash was in hot spots & itching;
Developed R calf pain on 1/16/21, progressively worsening over 3-4 weeks. Diagnosed with R posterior tibial DVT on 2/6/21 and started on apixaban.
After receiving the vaccine I started to run fever and chills a few hours after receiving the vaccine. Also at the vaccination site was very swollen as the size of a tennis ball, and it was very red and itchy. The site was also very swollen and very painful, the pain actually started to run up my arm and across my chest and it just felt very heavy. Also experienced a little bit of fatigue, and also  symptoms as if I was experiencing symptoms. Around Friday after the vaccination I actually started to feel a little better. The injection site has subsided but the area was bruised.
pt reported to observation staff feeling a tightness in her throat. pt was taken to triage area for additional observation and monitoring. there were no other symptoms reported by the patient. vital signs remained stable. no medications or oxygen were required. pt was allowed to leave after additional 20 minutes of monitoring.
At the shot site in my arm a week later it became red and feverish and hard for about two or three days also itching and then it was gone I understand that it was is now called covid-19 on
Initial unsolicited report received from non-health care professional on 08 Aug 2016. This case involves a female patient (age unknown) who was vaccinated with a dose of Dtap (batch number, expiry date, dose, dose in series, route and site of administration were not reported) on an unknown date. The patient had a medical history of Myasthenia Gravis. Illness at the time of vaccination was reported as unknown. It was unknown if the patient had any other vaccinations within four weeks of vaccinations. Concomitant medications were not reported. On an unknown date, unspecified timeframe following the vaccination, the patient had some type of reaction that she did not have info on. She felt reluctant to file since it was a long time ago. It was reported as "Unsure" if patient was hospitalized at the time of the reaction or the severity. Laboratory investigations were reported as unknown. Corrective treatment were not reported. The patient recovered from the event on an unknown date. List of documents held by sender: none.
I received my shot. I informed them of my allergies and was given the shot and asked to wait for 30 minutes to make sure I did not have a reaction.  I was fine for about 15-20 minutes then chest and arms turned bright red and I got all over itches.  Tongue started to tingle.  Itches and redness began to spread.  My heart rate and blood pressure when way up.  The ambulance was called.  I was going to ride with my husband to the hospital but then I got faint feeling and began to puke, along with a tightness in my throat so the ambulance took me and gave me an epi shot and benedryl and took me to the ER.
Pt came to clinic 6/28/13 and c/o (L) upper arm soreness and (L) side of neck soreness x4 days which started 1 week post Hep B #2.
shortness of breath; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 55-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 24Oct2021 as dose 2, single (Lot number: 32030BD), in right arm for covid-19 immunisation.  The patient's relevant medical history was not reported. There were no concomitant medications. Past drug history included: 13 yrs ago took tetanus, reaction(s): "Allergy: tetanus", notes: 13 yrs ago took tetanus; Whooping cough shot mix. it reduced my mobility, reaction(s): "reduced my mobility", notes: whooping cough shot mix. It reduced my mobility; Whooping cough shot mix. it reduced my mobility, reaction(s): "Allergy", notes: whooping cough shot mix. It reduced my mobility. Vaccination history included: BNT162b2 (Dose Number: 1, Batch/Lot No: 30155BA, Location of injection: Arm Right), administration date: 03Oct2021, when the patient was 55-year-old, for COVID-19 immunization. The following information was reported: DYSPNOEA (disability), outcome "not recovered", described as "shortness of breath". The event "shortness of breath" required physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative, notes: Agency. Therapeutic measures were not taken as a result of dyspnoea. Additional information: No illness other than vaccine reactions. Dose #2 - Vaccine administered at Pharmacy or Drug Store. No other vaccine in four weeks. No other medications in two weeks, 5 different Irregular Breathing Issues - My cardiologist classifies it as shortness of breath. The issue started in my sleep the night of my first dose. Each week I experience the issue. It slowly spread throughout the day by Jan. I waited until Jan for the issues to resolve. Since it grew worse I went to visit with my doctor. Since then I've undergone a vast amount of tests with specialist on every level at least 2-3 times a month. Specialist visits includes, Cardiology, Sleep Specialist, Allergist, Neurologist, Pulmonary Medicine, etc. Cardiology/Neurology just confirmed it's vaccine related. No Covid prior vaccination.
I had an increase protein and uric acid in my urine. I had swelling, in my face hands and feet. I was admitted to the hosptial for monitoring and I was diagnosed with mild preaclampsia. I will remain in the hosital until delivery. I am estimated to deliver twins on 03/29/2021
Pt. with parent for second pfizer vaccine. Pt. had no reaction with first vaccine. After 20 minutes, pt noted hives on his legs and chest. EMS alerted. No SOB, no difficulty breathing. No hx of anaphylaxis from vaccines. Pt. given 25mg benadryl at 1657. After rest of allotted wait time pt. states hives are decreasing and pt. has no worsening symptoms. Pt. exited facility with parent.
Upper left arm has been in pain since receiving the (required) vaccine. I?m surprised that no one is interested in the people who have not changed their daily routine, rarely wear a mask, and generally live life as they did pre-covid.
Fever and Chills 9th day post vaccination, took Motrin OTC Macular rash on the trunk, itchiness 10th day. Continued taking the Allegra. Still present on exam today but fading, nonpruritic. Retroauricular and posterior neck painful, swollen lymph nodes, subsided in 2 days, still palpable retroauricular the size of lima beans.
I did not have an adverse reaction to the vaccine. I was exposed to COVID-19 while on vacation. I tested positive on 05/27/2023. I went to an urgent care center, and I got a prescription for Paxlovid. I tolerated the medication without any complications. As of now, I have a loss of taste.
1 of 2 children vaxed from different lots who devel an inj site rxn described as redness, itching & welts surrounding site;welts also appeared on other places on the arm;no fever reported;atarax prescribed-pt recovered;
Mom called said child had whelps on left arm, leg, & back. This happened a few min. after leaving the clinic. Had child come back. There was a red area on leg & arm. It had gone down since mom called. BENADRYL given and sent home per Dr.
An itchy rash appeared on the left side (same side as the injection) the next morning. Today, a day later, it's itchy but not painful.
EXTREMELY HEAVY MENSTRUAL CYCLE; FLU LIKE SYMPTOMS (FEVER, FELT HOT, CHILLS, HEADACHE AND SORENESS/PAIN); This spontaneous report received from a patient concerned a 36 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, and batch number: 201A21A expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 08-APR-2021, the subject experienced flu like symptoms (fever, felt hot, chills, headache and soreness/pain). On an unspecified date, the subject experienced extremely heavy menstrual cycle. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from extremely heavy menstrual cycle, and flu like symptoms (fever, felt hot, chills, headache and soreness/pain). This report was non-serious. This case, from the same reporter is linked to 20210436455 and 20210438566.
TESTED POSITIVE FOR COVID ON  2-6-22; DECEASED 2-18-22
Fever, metallic taste in mouth, swelling in hands and feet, joint pain. Symptoms improved with ibuprofen the next day. Was advised to see his primary care provider, which he did. Pt. reports his PCP did not prescribe any meds or tests and cleared him to return to work
substantial hearing loss in his right ear; woke up with ringing in his right ear; This is a spontaneous report from a contactable consumer (patient). A 72-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 31Mar2021 at 10:00 (lot number: ER8737) as single dose for covid-19 immunisation, administered at the hospital. The patient received the first dose of bnt162b2 in Mar2021 at 10:00 (lot number: EN6208) for covid-19 immunisation. Medical history was reported as none. The patient's concomitant medications were not reported. The patient had no other vaccines in four weeks and no other medications in two weeks. The patient had no COVID prior vaccination and not COVID tested post vaccination. On 03Apr2021, patient woke up with ringing in his right ear at 5 AM and upon rising at 7:30 AM, he noticed substantial hearing loss in his right ear. The patient received treatment for the events. Outcome of the events were reported as recovered with lasting effects. The events resulted in doctor or other healthcare professional office/clinic visit and disability or permanent damage.
adult received a dose of Pediatric Engerix B; adult received a dose of Pediatric Engerix B; This case was reported by a consumer via call center representative and described the occurrence of underdose in a 27-year-old female patient who received HBV (Engerix B pediatric) (batch number P7294, expiry date 3rd January 2022) for prophylaxis.   Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 5th November 2021, the patient received Engerix B pediatric and Engerix B Pre-Filled Syringe Device. On 5th November 2021, unknown after receiving Engerix B pediatric and Engerix B Pre-Filled Syringe Device, the patient experienced underdose and adult use of a child product. On an unknown date, the outcome of the underdose and adult use of a child product were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were reported as follows: The age at vaccination was not reported but it could be 26 or 27 years. The Manager reported that, an adult patient received a dose of Pediatric Engerix B, which led to underdose and adult use of a child product. The reporter did not consented to follow-up
pt stayed home from school on 1FEB96 c/o achiness;2FEB96 went to school c/o not feeling well that afternoon a rash devel on arms & trunk & spread over body throughout weekend;pt seen 2FEB96 @ ER & given epi & Decadron;
Patient reported lightheadedness/dizziness and numbness in the arm the vaccine was administered. I monitored her for about 15 minutes and took her blood pressure and heart rate. I advised to visit an urgent care or call EMT if symptoms get worse or any difficulty breathing/swelling of lips or face or chest pain. Patient elected to go home and seek medical help if needed. Her step-father was present at the time of incident.
Arm began to feel warm: real red. Redness kept glowing and felt hard in the middle approximate size 8"x8" on 10/27/04.
Fever of 103-104deg F. 4-6 hrs after the vacciantion with DTaP, IPV and MMR. Continued fever for 24 hrs. Increased to 105.4 in the clinic. Treated with Advil.
between shot 2 and 3 started having chest pains and racing heart. Went to ER. After shot 3 started having daily headaches and blackouts. Mis-diagosed with Epilepsy. On Epilepsy medication for 12 months. 8-25-9 diagosed with Postural Orthostatic tachycardia syndrome.
Immed after inj c/o "numbness" (L) arm from delt to (L) hand. Also next day inj site red & edematous. Red, raised streak from deltoid to over (L) breast. Approx 3" long.
Developed mouth ulcers on left incide cheek and left side of tongue; Dentist thinks shingles; This is a spontaneous report received from a contactable consumer (patient). A 47-year-old female patient (non-pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EL3302), via an unspecified route of administration on arm right on 19Feb2021 00:15 at single dose for COVID-19 immunisation in hospital. The patient medical history was not reported. Concomitant medications included piper methysticum (KAVA); vitamin D [vitamin D NOS]; cetirizine hydrochloride (ZYRTEC) and ashwaganda. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient developed mouth ulcers on left inside cheek and left side of tongue on 22Feb2021 15:00. Dentist thinks shingles. Ulcers increased in pain and amount over the three weeks since the first vaccine. The events result in doctor or other healthcare professional office/clinic visit. The patient received treatment with unspecified antiviral medication. The patient was not diagnosed with COVID-19 Prior to vaccination. The patient has not been tested for COVID-19 Since the vaccination. Later the patient received her second dose of BNT162B2 (Lot number: En6208) on 11Mar2021, on right arm. The events were assessed as non-serious by the reporter. The outcome of the events was reported as unknown.
Two days after first covid vaccine had four days of vertigo attacks she said they started in the evening and lasted four hours.
infection of the lungs, pneumonia; respiratory injuries; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concurrent conditions, medical history, or concomitant medications.  On 13-NOV-2017, the patient was inoculated with zoster vaccine live (ZOSTAVAX) for routine maintenance and for its intended purpose: the prevention of shingles (herpes zoster) (dose, route of administration, lot # and expiration date were not provided). On an unspecified date in November 2017, reported as within ten days after receiving zoster vaccine live (ZOSTAVAX), the patient suffered an infection of lungs, pneumonia and other life threatening respiratory injuries resulting in hospitalization. These conditions resulted in prolonged medical treatment. As a direct and proximate result of zoster vaccine live (ZOSTAVAX) vaccine, the patient suffered severe injuries and disfigurement not present prior to using the zoster vaccine live (ZOSTAVAX), which were directly caused by the zoster vaccine live (ZOSTAVAX) vaccine. The patient also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of the zoster vaccine live (ZOSTAVAX), the patient sustained severe and disfiguring personal injuries, the patient suffered serious, progressive, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient has suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the events of pneumonia and respiratory injuries were reported as not recovered. The reporter considered the events to be related to zoster vaccine live (ZOSTAVAX).  The events of pneumonia and respiratory injuries were considered to be disabling and life threatening. Upon internal review, the event of pneumonia was considered to be medically significant.
This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Feeling woozy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Mar-2021 at 9:00 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced DIZZINESS (Feeling woozy). At the time of the report, DIZZINESS (Feeling woozy) had not resolved.            Treatment details was not provided. Concomitant medications included unspecified medications for blood pressure  Action taken with mRNA-1273 in response to the event was Not Applicable   This case was linked to US-MODERNATX, INC.-MOD-2021-054884 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-054884:Same reporter link
Approximately 05:30PM on day after vaccines felt general malaise, achy, sweaty, temperature, no vomiting, no nausea, no diarrhea, also complained of headache.  Took Advil.  03/14/2006 feeling improved.
inc fever on 16MAR95-broke out from waist down; rash remained on body until 19MAR95; fever gradually subsided; p/ER visit was given Antihistamine & ATB; nl @ this time
Raised rash on face and neck about 3-4 hrs after vaccines administered.  Pruritic.  Plans to go to PMD today.  And shortness of breath, difficulty breathing, extreme fatigue.
Headache, Myalgia, Arthralgia, Diarrhea, NauseaVomiting, Fatigue Narrative:  Other Relevant History:
Shaking of legs; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Shaking of legs) and NAUSEA (Nausea) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014F21A) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID, ASCORBIC ACID (ASPIRIN COMPOUND [ACETYLSALICYLIC ACID;ASCORBIC ACID]) for Anticoagulant therapy, ATORVASTATIN for Cholesterol, FUROSEMIDE (FUROSIMIDE) for Hypertension.    On 25-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Sep-2021, the patient experienced TREMOR (Shaking of legs) and NAUSEA (Nausea). At the time of the report, TREMOR (Shaking of legs) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Carbetolol is used as concomitant medication for hypertension.  No treatment information is provided.